1 / 4

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients. Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606. Mean changes in eGFR (bars) with 95% confidence intervals (whiskers) for each rosuvastatin dose

walker-jefferson
Download Presentation

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606

  2. Mean changes in eGFR (bars) with 95% confidence intervals (whiskers) for each rosuvastatin dose Numbers across the bottom represent the patient number for each dose group; *p<0.01 versus baseline Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606

  3. Baseline demographic and clinical characteristics for placebo-controlled trials Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606

  4. Change in estimated glomerular filtration rate by subgroups Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606

More Related